PUBLISHER: KBV Research | PRODUCT CODE: 1245579
PUBLISHER: KBV Research | PRODUCT CODE: 1245579
Europe Sciatica Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Drug Class (Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others), By Country and Growth Forecast, 2022 - 2028
The Europe Sciatica Treatment Market would witness market growth of 3.1% CAGR during the forecast period (2022-2028).
Sciatica produces tingling, numbness, and a burning feeling that radiates from the lower back and upper buttocks down the back of the hamstring to the back of the foot. Leg discomfort, hip pain, buttock pain, and lumbar pain are the effects of this. There are times when the discomfort extends around the hips or buttocks, feeling something comparable to a hip ache. Walking difficulties might result from severe sciatica.
Surgery is indicated if the discomfort lasts longer than three months. The underlying reasons for sciatica are therapy's main focus, leading to quicker pain alleviation and recovery. The therapy process makes little or no use of electromagnetic waves or medications. As a result, this kind of therapy has no adverse effects on the body. Stress and muscular trigger points are relieved during sciatica therapy. It may trigger the body's innate healing process all over. The patient may avoid spinal surgery as a result. Also, it significantly lessens muscular strains and ligament sprains.
In England, half of the individuals (or 63% of adults) who are overweight or obese will be living there by 2020. As they graduate from elementary school, one in three kids is already overweight or obese, and one in five of them do. The most disadvantaged segments of society have the greatest rates of obesity. According to comparable international figures on overweight and obesity from 2008 (1), 60.5% of adults in Germany (> 20 years old) were heavy, and 25.1% were obese. Men (66.8%) were more likely than women (54.5%) to be overweight. It is anticipated that the rising incidence of obesity and overweight would increase the risk of sciatica. The sciatica treatment market is expected to increase in Europe because of all these reasons.
The Germany market dominated the Europe Sciatica Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $55,234.7 Thousands by 2028. The UK market is anticipated to grow a CAGR of 2.3% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 3.9% during (2022 - 2028).
Based on Type, the market is segmented into Chronic, Acute and Others. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies and Online Providers. Based on Drug Class, the market is segmented into Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sorrento Therapeutics, Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Novartis AG, and Cadila Healthcare Ltd. (Zydus Cadila)
Scope of the Study
Market Segments covered in the Report:
By Type
- Chronic
- Acute
- Others
By Distribution Channel
- Retail & Specialty Pharmacies
- Hospital Pharmacies
- Online Providers
By Drug Class
- Non-Steroidal anti-inflammatory
- Steroids
- Antidepressants
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Abbott Laboratories
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sorrento Therapeutics, Inc.
- Alkem Laboratories Ltd.
- Amneal Pharmaceuticals, Inc.
- Aurobindo Pharma Limited
- Novartis AG
- Cadila Healthcare Ltd. (Zydus Cadila)
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Sciatica Treatment Market, by Type
- 1.4.2 Europe Sciatica Treatment Market, by Distribution Channel
- 1.4.3 Europe Sciatica Treatment Market, by Drug Class
- 1.4.4 Europe Sciatica Treatment Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Europe Sciatica Treatment Market by Type
- 3.1 Europe Chronic Market by Country
- 3.2 Europe Acute Market by Country
- 3.3 Europe Others Market by Country
Chapter 4. Europe Sciatica Treatment Market by Distribution Channel
- 4.1 Europe Retail & Specialty Pharmacies Market by Country
- 4.2 Europe Hospital Pharmacies Market by Country
- 4.3 Europe Online Providers Market by Country
Chapter 5. Europe Sciatica Treatment Market by Drug Class
- 5.1 Europe Non-Steroidal anti-inflammatory Market by Country
- 5.2 Europe Steroids Market by Country
- 5.3 Europe Antidepressants Market by Country
- 5.4 Europe Others Market by Country
Chapter 6. Europe Sciatica Treatment Market by Country
- 6.1 Germany Sciatica Treatment Market
- 6.1.1 Germany Sciatica Treatment Market by Type
- 6.1.2 Germany Sciatica Treatment Market by Distribution Channel
- 6.1.3 Germany Sciatica Treatment Market by Drug Class
- 6.2 UK Sciatica Treatment Market
- 6.2.1 UK Sciatica Treatment Market by Type
- 6.2.2 UK Sciatica Treatment Market by Distribution Channel
- 6.2.3 UK Sciatica Treatment Market by Drug Class
- 6.3 France Sciatica Treatment Market
- 6.3.1 France Sciatica Treatment Market by Type
- 6.3.2 France Sciatica Treatment Market by Distribution Channel
- 6.3.3 France Sciatica Treatment Market by Drug Class
- 6.4 Russia Sciatica Treatment Market
- 6.4.1 Russia Sciatica Treatment Market by Type
- 6.4.2 Russia Sciatica Treatment Market by Distribution Channel
- 6.4.3 Russia Sciatica Treatment Market by Drug Class
- 6.5 Spain Sciatica Treatment Market
- 6.5.1 Spain Sciatica Treatment Market by Type
- 6.5.2 Spain Sciatica Treatment Market by Distribution Channel
- 6.5.3 Spain Sciatica Treatment Market by Drug Class
- 6.6 Italy Sciatica Treatment Market
- 6.6.1 Italy Sciatica Treatment Market by Type
- 6.6.2 Italy Sciatica Treatment Market by Distribution Channel
- 6.6.3 Italy Sciatica Treatment Market by Drug Class
- 6.7 Rest of Europe Sciatica Treatment Market
- 6.7.1 Rest of Europe Sciatica Treatment Market by Type
- 6.7.2 Rest of Europe Sciatica Treatment Market by Distribution Channel
- 6.7.3 Rest of Europe Sciatica Treatment Market by Drug Class
Chapter 7. Company Profiles
- 7.1 Abbott Laboratories
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
- 7.2 Johnson & Johnson
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental &Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.3 Teva Pharmaceutical Industries Ltd.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Regional Analysis
- 7.3.4 Research & Development Expenses
- 7.4 Sun Pharmaceutical Industries Ltd.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional & Segmental Analysis
- 7.4.4 Research & Development Expenses
- 7.5 Sorrento Therapeutics, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental Analysis
- 7.5.4 Research & Development Expenses
- 7.6 Alkem Laboratories Ltd.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.7 Amneal Pharmaceuticals, Inc.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental
- 7.7.4 Research & Development Expenses
- 7.8 Aurobindo Pharma Limited
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expense
- 7.9 Novartis AG
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
- 7.10. Cadila Healthcare Ltd. (Zydus Cadila)
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Segmental and Regional Analysis
- 7.10.4 Research & Development Expense
LIST OF TABLES
- TABLE 1 Europe Sciatica Treatment Market, 2018 - 2021, USD Thousands
- TABLE 2 Europe Sciatica Treatment Market, 2022 - 2028, USD Thousands
- TABLE 3 Europe Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
- TABLE 4 Europe Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
- TABLE 5 Europe Chronic Market by Country, 2018 - 2021, USD Thousands
- TABLE 6 Europe Chronic Market by Country, 2022 - 2028, USD Thousands
- TABLE 7 Europe Acute Market by Country, 2018 - 2021, USD Thousands
- TABLE 8 Europe Acute Market by Country, 2022 - 2028, USD Thousands
- TABLE 9 Europe Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 10 Europe Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 11 Europe Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
- TABLE 12 Europe Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
- TABLE 13 Europe Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Thousands
- TABLE 14 Europe Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Thousands
- TABLE 15 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Thousands
- TABLE 16 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Thousands
- TABLE 17 Europe Online Providers Market by Country, 2018 - 2021, USD Thousands
- TABLE 18 Europe Online Providers Market by Country, 2022 - 2028, USD Thousands
- TABLE 19 Europe Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
- TABLE 20 Europe Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
- TABLE 21 Europe Non-Steroidal anti-inflammatory Market by Country, 2018 - 2021, USD Thousands
- TABLE 22 Europe Non-Steroidal anti-inflammatory Market by Country, 2022 - 2028, USD Thousands
- TABLE 23 Europe Steroids Market by Country, 2018 - 2021, USD Thousands
- TABLE 24 Europe Steroids Market by Country, 2022 - 2028, USD Thousands
- TABLE 25 Europe Antidepressants Market by Country, 2018 - 2021, USD Thousands
- TABLE 26 Europe Antidepressants Market by Country, 2022 - 2028, USD Thousands
- TABLE 27 Europe Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 28 Europe Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 29 Europe Sciatica Treatment Market by Country, 2018 - 2021, USD Thousands
- TABLE 30 Europe Sciatica Treatment Market by Country, 2022 - 2028, USD Thousands
- TABLE 31 Germany Sciatica Treatment Market, 2018 - 2021, USD Thousands
- TABLE 32 Germany Sciatica Treatment Market, 2022 - 2028, USD Thousands
- TABLE 33 Germany Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
- TABLE 34 Germany Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
- TABLE 35 Germany Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
- TABLE 36 Germany Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
- TABLE 37 Germany Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
- TABLE 38 Germany Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
- TABLE 39 UK Sciatica Treatment Market, 2018 - 2021, USD Thousands
- TABLE 40 UK Sciatica Treatment Market, 2022 - 2028, USD Thousands
- TABLE 41 UK Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
- TABLE 42 UK Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
- TABLE 43 UK Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
- TABLE 44 UK Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
- TABLE 45 UK Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
- TABLE 46 UK Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
- TABLE 47 France Sciatica Treatment Market, 2018 - 2021, USD Thousands
- TABLE 48 France Sciatica Treatment Market, 2022 - 2028, USD Thousands
- TABLE 49 France Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
- TABLE 50 France Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
- TABLE 51 France Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
- TABLE 52 France Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
- TABLE 53 France Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
- TABLE 54 France Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
- TABLE 55 Russia Sciatica Treatment Market, 2018 - 2021, USD Thousands
- TABLE 56 Russia Sciatica Treatment Market, 2022 - 2028, USD Thousands
- TABLE 57 Russia Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
- TABLE 58 Russia Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
- TABLE 59 Russia Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
- TABLE 60 Russia Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
- TABLE 61 Russia Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
- TABLE 62 Russia Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
- TABLE 63 Spain Sciatica Treatment Market, 2018 - 2021, USD Thousands
- TABLE 64 Spain Sciatica Treatment Market, 2022 - 2028, USD Thousands
- TABLE 65 Spain Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
- TABLE 66 Spain Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
- TABLE 67 Spain Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
- TABLE 68 Spain Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
- TABLE 69 Spain Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
- TABLE 70 Spain Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
- TABLE 71 Italy Sciatica Treatment Market, 2018 - 2021, USD Thousands
- TABLE 72 Italy Sciatica Treatment Market, 2022 - 2028, USD Thousands
- TABLE 73 Italy Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
- TABLE 74 Italy Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
- TABLE 75 Italy Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
- TABLE 76 Italy Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
- TABLE 77 Italy Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
- TABLE 78 Italy Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
- TABLE 79 Rest of Europe Sciatica Treatment Market, 2018 - 2021, USD Thousands
- TABLE 80 Rest of Europe Sciatica Treatment Market, 2022 - 2028, USD Thousands
- TABLE 81 Rest of Europe Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
- TABLE 82 Rest of Europe Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
- TABLE 83 Rest of Europe Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
- TABLE 84 Rest of Europe Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
- TABLE 85 Rest of Europe Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
- TABLE 86 Rest of Europe Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
- TABLE 87 Key Information - Abbott Laboratories
- TABLE 88 Key information -Johnson & Johnson
- TABLE 89 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 90 Key Information - Sun Pharmaceutical Industries Ltd.
- TABLE 91 Key Information - Sorrento Therapeutics, Inc.
- TABLE 92 Key Information - Alkem Laboratories Ltd.
- TABLE 93 Key Information - Amneal Pharmaceuticals, Inc.
- TABLE 94 key information - Aurobindo Pharma Limited
- TABLE 95 Key Information - Novartis AG
- TABLE 96 Key Information - Cadila Healthcare Ltd.
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Swot analysis: Abbott laboratories
